Gene Query: F2RL1

Dataset Description Geneva Score
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 144.36
Differential analysis of gene regulation at transcript resolution by RNA-Seq 144.36
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 118.94
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 118.94
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 115.59
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 104.31
MYCi361 regulates MYC target genes 94.88
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 84.75
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 84.75
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 83.26
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 83.26
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 81.8
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 81.63
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 75.0
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 71.92
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 71.92
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 67.22
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 64.75
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 59.79
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 57.35
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 56.21
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 52.3
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 50.08
RNA-seq analyses of human prostate cancer cells 48.33
GATA3-mediated chromatin reprogramming in breast cancer cells 45.77
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 45.32
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 44.06
Neurofibroma 43.16
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 43.16
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 42.17
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 41.57
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 41.57
Maturation of human iNSCs 40.27
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 40.12
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 40.12
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 38.26
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 38.1
Inhibition of TNBC metastasis by Gpx1 38.0
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 37.02
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 36.92
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 36.69
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 36.55
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 36.48
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 36.48
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 35.81
RNA-seq of human aneuploid cell lines with Trisomy 21 35.55
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 35.51
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 34.9
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 34.9
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 34.69
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 34.29
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 33.29
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 33.15
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 33.13
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 33.13
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 33.08
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 32.46
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 32.31
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 31.71
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 31.55
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 30.82
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 30.53
PGE2 mediated gene expression changes in human cervical stromal cells 29.95
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 29.77
BI Human Reference Epigenome Mapping Project 29.27
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 29.24
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 29.02
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 29.02
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 28.65
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 28.51
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 28.45
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 28.36
Regulation of highly expressed hCINAP on translatome 28.18
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 27.66
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 27.36
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 26.98
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 26.98
TCF7L1 knockdown in pancreatic cancer 26.91
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 26.58
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 26.58
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 26.48
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 26.31
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 26.28
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 26.17
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 25.74
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 25.73
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 25.21
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 25.05
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 25.05
Transcriptomic and gene ontology profiling of the human corneal cell types 25.0
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 24.76
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 24.39
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 24.25
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 24.08
Effect of disulfiram treatment on pediatric high grade glioma 23.85
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 23.7
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 23.32
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 23.2
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 22.23
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 22.14
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 22.09
WRN knockout effects upon gene expression in SW48 and OVK18 21.99
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 21.91
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 21.78
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 21.54
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 21.34
Identification of long noncoding RNAs regulated by p53 21.33
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 21.03
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 21.03
RNA-Seq analysis of breast cancer cells after shikonin treatment 20.93
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 20.71
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 20.71
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 20.42
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  20.24
Tpl-2 small molecule project 19.98
Tpl-2 and MEK small molecule inhibitors 19.98
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 19.92
Investigation about fibroblasts of different origins in culture 19.77
Generation of KRAS signatures using immortalized isogenic lung cells. 19.74
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 19.5
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 19.36
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 19.36
Effect of BB608 on Gene Expression in HNSCC Cell Line 19.27
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 19.23
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 19.21
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 18.98
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 18.95
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 18.83
Ribosomal footprinting of CN34-Parental and CN34-LM1a 18.76
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 18.59
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 18.31
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 18.31
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 18.27
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 18.18
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 17.94
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 17.94
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 17.82
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 17.79
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 17.79
RNA-Sequencing of HepG2 cells treated with TGFBeta 17.72
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 17.69
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 17.6
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 17.56
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 17.55
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 17.43
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 17.38
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 17.09
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 17.04
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 17.01
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 17.01
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 16.88
Postnatal lipids drive hepatocyte maturation 16.58
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 16.54
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 16.52
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 16.39
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 16.35
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 16.31
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 16.3
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 16.26
Depicting early human development and germ cell origin with porcine embryos 16.17
RNA-Seq in neutrophils from Antiphospholipid Syndrome 16.01
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 15.91
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 15.91
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 15.91
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 15.86
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 15.71
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 15.66
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 15.6
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 15.55
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 15.55
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 15.44
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 15.43
Ribosomal footprinting of MDA-Parental and MDA-LM2 15.39
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 15.25
RNA-seq of cells with TET1 knockout 15.2
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 15.11
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 15.07
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 14.9
Overexpression and knockdown experiment for circCSNK1G3 14.84
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 14.78
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 14.78
NHLRC1 re-expression in cancer cells 14.76
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 14.67
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 14.55
Identification of differentially expressed genes between senescence and senescence bypass cells 14.52
RNA sequencing analysis of selumetinib-resistant CRC cells lines 14.46
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 14.41
AUF-1 affected genes in human skin cells 14.35
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 14.29
RNA-seq analysis to identify the genes regulated by p53-SET interplay 14.18
Next Generation Sequencing of human SMA and healthy control Motor Neurons 14.17
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 13.95
Characterization of parental and rociletinib-resistant derived H1975 cell lines 13.92
Dynamic reorganization of nuclear architecture during human cardiogenesis 13.92
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 13.92
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 13.86
Global transcriptome analysis of WT versus HEB-/- hESCs 13.78
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 13.73
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 13.7
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 13.66
Region-specific Innate Antiviral Responses of the Human Epididymis 13.58
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 13.57
MYCi975 regulates MYC target genes 13.5
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 13.49
Identifying the molecular mode of action of itraconazole in colorectal cancer 13.17
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 13.12
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 13.11
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 13.11
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 13.06
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 13.02
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 13.02
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 13.0
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 12.86
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 12.85
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 12.84
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 12.84
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.84
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 12.81
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 12.81
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 12.77
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 12.77
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 12.76
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 12.61
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 12.58
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 12.56
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 12.56
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 12.49
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 12.49
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 12.46
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 12.39
Differentially expressed genes post knock down of lincDUSP26 12.34
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 12.33
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 12.3
Gene expression patterns define the hepatocyte-like cells derived by different strategies 12.26
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 12.26
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 12.11
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 12.09
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 12.07
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 12.02
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 12.0
G-quadruplex structures mark human regulatory chromatin 11.96
High-Throughput Kinetic Analysis of Fractional Killing 11.83
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 11.82
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 11.82
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 11.62
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 11.62
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 11.58
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 11.58
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 11.57
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 11.54
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 11.54
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 11.42
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 11.42
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 11.4
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 11.28
A549 cells and MSR-A549 cells 11.25
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 11.25
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 11.24
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 11.16
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 11.16
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 11.16
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 11.11
Role for citron kinase in prostate cancer growth 11.1
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 11.04
High level DNA repair gene expression in human ES cells 11.03
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 10.99
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 10.99
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 10.97
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 10.93
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 10.9
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 10.9
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 10.86
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 10.85
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 10.83
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 10.82
Generation of trichogenic adipose-derived stem cells by expression of three factors 10.81
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 10.8
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 10.76
Lineage specific differentiation is influenced by state of human pluripotency 10.76
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 10.75
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 10.75
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 10.68
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 10.65
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 10.64
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 10.59
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 10.59
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 10.58
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 10.54
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 10.51
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 10.49
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 10.44
Single-nucleotide-resolution mapping of HBV promoters using CAGE 10.43
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 10.43
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 10.42
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 10.41
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 10.37
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 10.37
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 10.3
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 10.27
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 10.26
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 10.26
BAF controls genome accessibility 10.23
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 10.21
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 10.13
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 10.13
ARID1A and ARID1B loss in HCT116 and TOV21G cells 10.11
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 10.1
Knockdown of ADNP in HCT116 colon cancer cells 9.99
CSL RNA-Seq on HKC and SCC cell lines 9.98
CSL 9.98
CD73 knockdown effect in pancreatic cancer cell lines 9.86
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 9.85
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 9.83
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 9.82
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 9.82
A prostate cancer chromatin interaction map 9.81
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 9.8
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 9.75
RNA-seq analysis of breast cancer 9.74
RNA-seq analysis and shRNA screen of breast cancer 9.74
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 9.68
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 9.68
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 9.65
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 9.52
Selective expression of long non-coding RNAs in a breast cancer cell progression model 9.39
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 9.37
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 9.32
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 9.26
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 9.25
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 9.22
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 9.2
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 9.14
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 9.14
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 9.1
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 9.02
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 8.98
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 8.94
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 8.92
Gene expression analysis of human liver progenitor-like cells in culture 8.92
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 8.89
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 8.89
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 8.76
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 8.76
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 8.68
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 8.66
Gene profiling of human adult and pediatric liver cancer cells 8.55
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 8.52
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 8.49
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 8.3
Transcriptional landscape changes during human embryonic stem cell derivation 8.25
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 8.1
CHD1 regulates cell fate determination by activation of differentiation-induced genes 8.02
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 7.98
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 7.98
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 7.83
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 7.72
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 7.72
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 7.72
The MEF2B Regulatory Network - RNA-seq data 7.59
The MEF2B Regulatory Network 7.59
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 7.55
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 7.55
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 7.51
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 7.42
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 7.32
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 7.23
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 7.13
FOXP2's impact on the primate transcriptome 7.05
RNA seq_PDX2_SHP099 6.91
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 6.9
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 6.77
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 6.75
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.72
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 6.67
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 6.42
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 6.38
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 6.38
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 6.31
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.29
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 6.27
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 6.15
Differential gene expression in Jagged1 treated human dental pulp cells. 6.08
The effect of Abl kinases on non-small cell carcinoma global transcriptome 6.02
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 5.88
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 5.83
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 5.83
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 5.79
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 5.75
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 5.57
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 5.5
RNA splicing alteration on glioblastoma and normal neural stem cells 5.46
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 5.46
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 5.41
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 5.38
Total RNA sequencing of APC mutant and wt colonic organoids 5.35
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 5.32
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 5.28
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 5.23
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 5.13
hNSCs siRNA NOVA2 5.1
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 5.09
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 5.09
RNA-sequencing of healthy human skeletal myocytes 5.07
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 5.05
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 4.86
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 4.79
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 4.73
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 4.56
Redifferentiation of expanded human islet β cells by inhibition of ARX 4.53
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 4.46
Transcriptome profiling of A2M treated A549 Cell Line Samples 4.44
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 4.33
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 4.32
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.32
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 4.3
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 4.27
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 4.27
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.25
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 4.11
Noncoding regions are the main source of targetable tumor-specific antigens 4.1
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.1
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.03
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 4.02
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 3.83
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 3.79
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 3.57
Gene expression profile in breast cancer cell lines using RNA sequencing 3.56
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 3.48
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 3.48
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 3.48
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 3.45
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 3.4
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.38
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 3.32
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 3.31
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 3.21
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 2.93
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.89
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.78
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 2.78
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 2.72
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 2.71
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.66
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.65
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.56
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 2.45
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 2.32
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 2.32
Ribosome profiling upon inhibition of eIF4A 2.27
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 2.25
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 2.23
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 2.21
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 2.14
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 2.14
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.08
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 2.04
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.03
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 2.0
Human embryonic stem cells in E8 and AKIT culture medium 1.85
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 1.85
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 1.79
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 1.79
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.7
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.7
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.43
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 1.42
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 1.41
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 1.41
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 1.36
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 1.36
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 1.36
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 1.36
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 1.36
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 1.32
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.31
Gene expression analysis of human adenomas. 1.23
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.2
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.08
Positively selected enhancer elements endow tumor cells with metastatic competence 1.05
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.01
Investigate A2M treatment on human prostate cancer and mouse liver 0.81
Investigate A2M treatment on human prostate cancer xenograft in mice 0.81
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 0.8
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 0.8
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.78
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.78
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.74
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.5
UBC9 knockdown in bladder cancer T24 cell lines 0.46
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 0.44
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.41
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.4
Gene expression profile of CRC-derived HILEC 0.36
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.32
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.29
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.19
Derivation and differentiation of haploid human embryonic stem cells 0.07
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.06
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.06
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 0.06


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation